Occudo Quantitative Strategies LP Atreca, Inc. Transaction History

Occudo Quantitative Strategies LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.56 - $3.25 $3,945 - $8,219	-2,529 Reduced 8.77%	26,313 $47,000
Q1 2022 May 16, 2022	SELL	$1.61 - $5.2 $79,587 - $257,051	-49,433 Reduced 63.15%	28,842 $91,000
Q4 2021 Feb 14, 2022	BUY	$2.87 - $6.29 $224,649 - $492,349	78,275 New	78,275 $237,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.